ENSYSCE BIOSCIENCES, INC. (ENSC)

Every figure this model derived for ENSC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 123,643 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 676,704 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,846,210 AssetsCurrent 2026-06-30
current liabilities 4,068,106 LiabilitiesCurrent 2026-06-30
equity -781,697 StockholdersEquity 2026-06-30
interest expense 15,994 InterestExpenseNonoperating 2026-06-30
ocf -8,855,395 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 4,500,754 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc -15,315 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ENSC on one particular measure came for.

RatioValue
cash operating margin-281.23
current ratio0.7
current ratio reported0.7
dilution pct266.88
fcf margin-199.5
growth cv3.69
interest cover-791.64
operating margin-281.32
owner earnings margin-199.16
revenue growth-39.29
revenue growth per share-83.45
rule of 40-320.61
sbc pct revenue-0.34

What to be careful about

What this model itself distrusts about ENSC's figures. Written by the derivation as it ran, not added afterwards.